Anticalin in Medical Technology
Anticalin in Biological Technology
Pieris Raises EUR 25 M (US$ 38 M) in Series B Financing Round
...o, the Company applies a balanced risk business model to
the development of anticalin
About Anticalin(R) Technology
Anticalins(R) are eng...ound and modulated through a single molecule.
Pieris exclusively owns the anticalin
patent estate, which offers
complete freedom to operate outside the patent ...